News

23andMe struck a deal last month with Regeneron Pharmaceuticals Inc., but Wojcicki complained about the bidding process, ...
The California-based nonprofit founded by the former 23andMe CEO is set to close the $305 million deal in coming weeks.
Beleaguered genetic testing company 23andMe announced Friday that it has reached an agreement to sell itself to TTAM Research ...
Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron ...
Regeneron is backing away from buying the DNA-testing company after a nonprofit controlled by co-founder Wojcicki made a ...
Anne Wojcicki's nonprofit will acquire substantially all of 23andMe's assets for $305 million, the company announced on ...
Explore more
Wojcicki, a co-founder and former CEO of 23andMe, is buying ‘substantially all’ of the company’s assets through a nonprofit.
The co-founder of bankrupt genetic analysis company 23andMe won an auction for the firm’s assets, agreeing, along with a ...
The genetic testing company 23andMe is poised to be sold to a nonprofit run by the company's former chief executive Anne ...
Anne Wojcicki is set to regain control of 23andMe after a nonprofit she controls topped Regeneron Pharmaceuticals' bid for ...
Rep. Gill grilled 23andMe's co-founder Anne Wojcicki during a House hearing where she revealed that she did not understand ...
Me, which became a household name for its genetic testing services, is set to emerge from bankruptcy as a nonprofit.